Skip to main content

Table 8 Changes in intermediate patient outcomes°

From: Effectiveness of the introduction of a Chronic Care Model-based program for type 2 diabetes in Belgium

 

Intervention period

Δ

01/01/04-01/01/07

P value*

 

01/01/2004

01/01/2007

  

HbA1c (%)

    

   Intervention

7.55(7.48-7.62)

7.06(7.00-7.12)

-0.49(p < 0.0001)

0.4207

   Control

7.44(7.34-7.53)

6.90(6.83-6.98)

-0.54(p < 0.0001)

 

TC (mg/dl)

    

   Intervention

199.07(197.01-201.13)

173.94(171.85-176.04)

-25.13(p < 0.0001)

0.0021 (1)

   Control

199.44(197.03-201.90)

180.60(177.83-183.41)

-18.84(p < 0.0001)

 
  1. °linear mixed model; Δ = evolution; *P value for the evolution between the intervention and control region, (1) significantly greater change in the intervention region (2) significantly greater change in the control region